Trials / Completed
CompletedNCT04152187
Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension
Investigation of the Effects of Inspiratory Muscle Training in Patients With Pulmonary Hypertension
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Dokuz Eylul University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to determine the possible effects of inspiratory muscle training on cardiovascular, respiratory, physical and psychosocial functions in patients with PH.
Detailed description
Pulmonary Hypertension (PH) is a hemodynamic finding related to increase in pulmonary artery pressure. Because PH disease is a progressive, rare disease, it is important for this disease group to prolong the life span and to increase the quality of life and functional capacity. PH patients have been shown to have weakness in peripheral and respiratory muscles. Patients will be randomly assigned to the inspiratory muscle training and control group. Inspiratory muscle training will be initiated in accordance with the patient at a range of 40-60%. İnspiratory muscle training will be given based on the assessments by the physiotherapist. Patients with PH who come to the routine outpatient clinic and volunteer will be included in the study. The first session will be the evaluation session and the 8-week inspiratory muscle training will be given, the other group will be the control group only. Dyspnoea, diaphragm thickness, pulmonary function, respiratory and peripheral muscle strength, blood pressure, arterial stiffness, physical activity, anxiety, depression and quality of life assessments will be repeated before and after the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Inspiratory muscle training | The treatment group will receive inspiratory muscle training. |
Timeline
- Start date
- 2019-11-11
- Primary completion
- 2022-08-18
- Completion
- 2022-10-18
- First posted
- 2019-11-05
- Last updated
- 2022-11-15
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04152187. Inclusion in this directory is not an endorsement.